LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Technology bit.bio utilizes patent-protected opti-ox precision cell programming technology, enabling deterministic programming of human cells at an industrial scale 10 times faster than conventional methods. This innovative approach opens up opportunities for partnerships with companies seeking faster and more precise cell programming solutions.

Diverse Product Portfolio With products like ioAstrocytes and ioMotor Neurons, bit.bio offers a range of highly characterized, scalable human cell products for research and drug discovery in areas like neurological diseases and ALS. This diverse portfolio presents sales opportunities for collaborations with research institutions and pharmaceutical companies looking for advanced cellular models.

Strategic Collaborations The recent partnerships with The Michael J. Fox Foundation and integration with Ginkgo Bioworks showcase bit.bio's commitment to advancing research and drug discovery in Parkinson's disease and other areas. Leveraging these collaborations can position the company favorably for sales engagements with organizations focused on innovative biotech solutions.

Exceptional Talent Acquisition The appointment of Przemek Obloj, a seasoned professional with extensive financial and investment expertise in health, life sciences, and technology sectors, as Chief Financial Officer, strengthens bit.bio's leadership team. This strategic talent acquisition can be leveraged to build relationships with investors and strategic partners seeking to support high-growth biotechnology companies.

Market Expansion With the launch of ioAstrocytes and ioMotor Neurons, as well as the expansion of the ioCells product range, bit.bio demonstrates a commitment to market expansion and product innovation. This growth trajectory presents sales opportunities to capitalize on the increasing demand for advanced cell products in the biotech industry.

Similar companies to bit.bio

bit.bio Tech Stack

bit.bio uses 8 technology products and services including TrackJs, Cloudflare, HubSpot Cookie Policy Banner, and more. Explore bit.bio's tech stack below.

  • TrackJs
    Analytics
  • Cloudflare
    Content Management System
  • HubSpot Cookie Policy Banner
    Cookie Compliance
  • jQuery Migrate
    Javascript Libraries
  • RSS
    Miscellaneous
  • Cisco
    Network Hardware
  • iOS
    Programming Languages
  • Greenhouse
    Recruitment Marketing

Media & News

bit.bio's Email Address Formats

bit.bio uses at least 1 format(s):
bit.bio Email FormatsExamplePercentage
First.Last@bit.bioJohn.Doe@bit.bio
71%
First@bit.bioJohn@bit.bio
18%
Last@bit.bioDoe@bit.bio
6%
FLast@bit.bioJDoe@bit.bio
5%

Frequently Asked Questions

Where is bit.bio's headquarters located?

Minus sign iconPlus sign icon
bit.bio's main headquarters is located at The Dorothy Hodgkin Building Babraham Research Campus Cambridge, Cambridgeshire CB22 3FH GB. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is bit.bio's official website and social media links?

Minus sign iconPlus sign icon
bit.bio's official website is bit.bio and has social profiles on LinkedIn.

How much revenue does bit.bio generate?

Minus sign iconPlus sign icon
As of October 2024, bit.bio's annual revenue reached $15M.

What is bit.bio's SIC code NAICS code?

Minus sign iconPlus sign icon
bit.bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does bit.bio have currently?

Minus sign iconPlus sign icon
As of October 2024, bit.bio has approximately 211 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer: P. O.Chief Scientific Officer (svp): E. M.Founder And Ceo: M. K.. Explore bit.bio's employee directory with LeadIQ.

What industry does bit.bio belong to?

Minus sign iconPlus sign icon
bit.bio operates in the Biotechnology Research industry.

What technology does bit.bio use?

Minus sign iconPlus sign icon
bit.bio's tech stack includes TrackJsCloudflareHubSpot Cookie Policy BannerjQuery MigrateRSSCiscoiOSGreenhouse.

What is bit.bio's email format?

Minus sign iconPlus sign icon
bit.bio's email format typically follows the pattern of . Find more bit.bio email formats with LeadIQ.

When was bit.bio founded?

Minus sign iconPlus sign icon
bit.bio was founded in 2016.
bit.bio

bit.bio

Biotechnology ResearchCambridgeshire, United Kingdom201-500 Employees

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. 

We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines.

Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies.

To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision.

Collaboration is at the heart of bit.bio. Join us on our journey. 

For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks

Section iconCompany Overview

Headquarters
The Dorothy Hodgkin Building Babraham Research Campus Cambridge, Cambridgeshire CB22 3FH GB
Website
bit.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
201-500

Section iconFunding & Financials

  • $10M$50M

    bit.bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    bit.bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.